46 companies

Limbach Holdings

Market Cap: US$1.0b

Operates as a building systems solution company in the United States.

New

LMB

US$82.48

7D

0.9%

1Y

-18.2%

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$37.32

7D

1.3%

1Y

-5.2%

Global Industrial

Market Cap: US$1.2b

Through its subsidiaries, operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in the United States and Canada.

GIC

US$32.60

7D

8.6%

1Y

34.9%

Applied Industrial Technologies

Market Cap: US$10.2b

Distributes industrial motion, power, control, and automation technology solutions in the United States, Canada, Mexico, Australia, New Zealand, Singapore, and Costa Rica.

AIT

US$289.94

7D

13.1%

1Y

9.4%

Pegasystems

Market Cap: US$6.8b

Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.

PEGA

US$39.26

7D

-20.4%

1Y

-27.6%

Vita Coco Company

Market Cap: US$3.3b

Develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific.

COCO

US$55.00

7D

1.5%

1Y

48.3%

Pinterest

Market Cap: US$14.0b

Operates as a visual search and discovery platform in the United States, Canada, Europe, and internationally.

PINS

US$19.87

7D

-11.9%

1Y

-40.3%

ResMed

Market Cap: US$36.6b

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.

RMD

US$263.03

7D

2.1%

1Y

8.4%

Stride

Market Cap: US$3.6b

Provides proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally.

LRN

US$86.45

7D

4.5%

1Y

-37.6%

ACADIA Pharmaceuticals

Market Cap: US$4.2b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$24.23

7D

-5.4%

1Y

23.6%

Page 2 of 2